Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
GlaxoSmithKline amplifies the agony of ‘la culebrilla’ to raise shingles awareness with Spanish speakers
4 years ago
Marketing
Watch out, Novartis: Eli Lilly, Boehringer Ingelheim notch broad heart failure OK for Jardiance
4 years ago
FDA+
Sanofi signals a big interest in oncology as it adds a cancer R&D star to the board
4 years ago
Last year was one of the 'most eventful in US biosimilars history,' but these analysts say 2022 should be 'a turning point'
4 years ago
AbbVie slams the pension door to new hires as Big Pharma holdouts finally join the migration to 401Ks
4 years ago
BioMarin ‘turning the corner’ on profits with optimism on Voxzogo, Roctavian — but questions remain
4 years ago
Marketing
On a roll, Recipharm wraps up its second and third CDMO acquisitions this month
4 years ago
Manufacturing
Pfizer drops case against ex-staffer accused of stealing trade secrets — including details about Covid-19 vaccine
4 years ago
People
Law
'F--- the feds': Martin Shkreli barred from running all public companies as judge decries remorseless behavior
4 years ago
Unidentified witnesses accuse Bristol Myers of scuttling timely FDA move on liso-cel to avoid $6.4B payout
4 years ago
Spectrum's penny stock takes another hit as CFO quietly plans exit
4 years ago
People
Building on CRISPR success, Intellia inks deal for new manufacturing facility in Waltham, MA
4 years ago
Cell/Gene Tx
Manufacturing
Akebia scrapes together $85M war chest to commercialize vada as PDUFA date looms
4 years ago
Financing
AbbVie sees a megablockbuster in Vraylar. Could a new depression indication push peak sales past $4B?
4 years ago
Pharma sustainability: Amgen debuts $750M ‘green bond,’ Merck initiates ESG goal review
4 years ago
Marketing
Manufacturing reorg at Merck KGaA inspires a $500M+ investment in mRNA tech
4 years ago
Manufacturing
AstraZeneca's Pascal Soriot brought home nearly $19M last year, dwarfing some of Europe's highest pharma pay packages
4 years ago
Mallinckrodt chalks up CRL to packaging and labeling facility struggles
4 years ago
Manufacturing
Democrats urge HHS to 'march-in' or enable 'government-use' rights to make Xtandi less expensive
4 years ago
Blatant abuse of Chapter 11? J&J says its use of 'Texas two-step' is all about fairness
4 years ago
Law
End of an era at AstraZeneca as Leif Johansson preps exit as chairman. So where does that leave Soriot?
4 years ago
People
It looks like the final round of Emergent's AstraZeneca Covid-19 doses have been released
4 years ago
Manufacturing
Q&A: Astellas’ Anthony Yanni leading the charge to embed patient voices' in pharma business model
4 years ago
Marketing
MarketingRx roundup: GSK switches up Cabenuva TV ad with newly approved dosing; AZ debuts new Breztri TV
4 years ago
Marketing
First page
Previous page
220
221
222
223
224
225
226
Next page
Last page